Please login to the form below

Not currently logged in
Email:
Password:

David Novack leaves Novartis for Dynavax

Was global head of technical operations and supply chain for diagnostics at Swiss pharma firm

Vaccines-focused biopharma Dynavax has appointed David Novack, formerly of Novartis, to be its senior VP of operations and quality.

Novack was most recently global head of technical operations and supply chain for diagnostics at Novartis.

He also has senior vaccines experience at the pharma major, having previously served as global head of vaccine manufacturing strategy.

Prior to joining Novartis in 2006, Novack spent two years as VP, business development for vaccines company Vaxin.

From 1993 to 2004 Novack held several roles at MedImmune, working in business development, manufacturing and contract operations.

In his new role, he will support Dynavax as it prepares to advance hepatitis B vaccine Heplisav from a phase III candidate into a commercial product.

"David's background and experience will be a valuable addition to our senior management team," said president and chief medical officer, Dr Tyler Martin.

"We look forward to his contributions in the planning and implementation of a successful commercial manufacturing strategy for the advancement of Heplisav and long-term growth of the company."

In addition to Novack's appointment, Dynavax also announced that Stephen Tuck, VP, global technical operations is to step down at the end of March.

28th March 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics